Literature DB >> 18837834

Incidence of Hepatitis A in Argentina after vaccination.

M N Vacchino1.   

Abstract

In Argentina, the annual incidence rate of reported hepatitis A disease ranged from 70.5 to 173.8 per 100,000 during 1995-2004. A single dose universal hepatitis A immunization program aimed at children aged 12 months was started in June 2005. The aim was to observe the impact of universal vaccination against hepatitis A in Argentina. A longitudinal analysis of hepatitis A rates reported in Argentina since 1995 to the National Notifiable Diseases Surveillance System (SINAVE). Incidence rates in 2007 were compared with those for the prevaccination baseline period (1998-2002), overall and by age group and geographical regions. Overall vaccine coverage in Argentina was 95% in 2006 for the single dose. After initiating the program, a sharp decrease in disease rates was observed. The annual incidence of 10.2 per 100,000 during 2007 represents 88.0% reduction with respect to the average incidence rate for the period 1998-2002 (P < 0.001). For children aged 1 year, an 83.1% reduction in disease was observed in 2007, compared with the baseline period (P < 0.001). Furthermore, a sharp decline was also observed in all other age groups 87.1% [2-4 years], 88.7% [5-9 years], 83.6% [10-14 years], 78.8% [15-49 years], 20.7% [>50 years]. Also important reductions were observed in all Argentinian regions. Following the implementation of universal hepatitis vaccination with a single dose to children at 12 months of age, hepatitis A rates have declined substantially in Argentina. Monitoring is needed to verify that vaccination continues to proceed and that low rates are sustained.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18837834     DOI: 10.1111/j.1365-2893.2008.01029.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  22 in total

1.  Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine.

Authors:  Zhilun Zhang; Xiangjun Zhu; Yuansheng Hu; Miao Liang; Jin Sun; Yufei Song; Qi Yang; Haiquan Ji; Gang Zeng; Lifei Song; Jiangting Chen
Journal:  Hum Vaccin Immunother       Date:  2017-02-14       Impact factor: 3.452

2.  Comparison of immune persistence among inactivated and live attenuated hepatitis a vaccines 2 years after a single dose.

Authors:  Xiaoshu Zhang; Jing An; Aixia Tu; Xuefeng Liang; Fuqiang Cui; Hui Zheng; Yu Tang; Jianfeng Liu; Xuxia Wang; Ningjing Zhang; Hui Li
Journal:  Hum Vaccin Immunother       Date:  2016-08-05       Impact factor: 3.452

3.  Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.

Authors:  Eduardo Lazcano-Ponce; Carlos Conde-Gonzalez; Rosalba Rojas; Rodrigo DeAntonio; Luis Romano-Mazzotti; Yolanda Cervantes; Eduardo Ortega-Barria
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

Review 4.  Immunization against Hepatitis A.

Authors:  Daniel Shouval
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

5.  Hepatitis A: Epidemiology and prevention in developing countries.

Authors:  Elisabetta Franco; Cristina Meleleo; Laura Serino; Debora Sorbara; Laura Zaratti
Journal:  World J Hepatol       Date:  2012-03-27

6.  Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.

Authors:  Ana Martínez; Sonia Broner; M Rosa Sala; Sandra Manzanares-Laya; Pere Godoy; Caritat Planas; Sofia Minguell; Nuria Torner; Mireia Jané; Angela Domínguez; The Working Group For The Study Of The Immune Status In Health Care; For The Study Of Hepatitis A In Catalonia
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

7.  Model-based projections of the population-level impact of hepatitis A vaccination in Mexico.

Authors:  Thierry Van Effelterre; Rodrigo De Antonio-Suarez; Adrian Cassidy; Luis Romano-Mazzotti; Cinzia Marano
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

8.  Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in children.

Authors:  Monjori Mitra; Nitin Shah; Mma Faridi; Apurba Ghosh; V S Sankaranarayanan; Anju Aggarwal; Suparna Chatterjee; Nisha Bhattacharyya; Ganesh Kadhe; Gaurav Vishnoi; Amey Mane
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Epidemiology of hepatitis A virus in Africa among persons aged 1-10 years: a systematic review protocol.

Authors:  Tiwonge J Kanyenda; Leila H Abdullahi; Gregory D Hussey; Benjamin M Kagina
Journal:  Syst Rev       Date:  2015-09-26

10.  Change in Hepatitis A Seroprevalence among U.S. Children and Adolescents: Results from the National Health and Nutrition Examination Survey 2003-2006 and 2007-2010.

Authors:  Deanna Kruszon-Moran; R Monina Klevens; Geraldine M McQuillan
Journal:  Vaccines (Basel)       Date:  2013-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.